Battery-Operated Neurosurgical Power Systems Market Global Report 2026

The battery-operated neurosurgical power systems market size has grown rapidly in recent years. It will grow from $0.77 billion in 2025 to $0.89 billion in 2026 at a compound annual growth rate (CAGR) of 16.0%. The growth in the historic period can be attributed to increasing volume of neurosurgical procedures, rising adoption of minimally invasive neurosurgery, growing demand for cordless surgical equipment, increasing investments in advanced operating room infrastructure, expanding availability of rechargeable surgical power systems.

The battery-operated neurosurgical power systems market size is expected to see rapid growth in the next few years. It will grow to $1.62 billion in 2030 at a compound annual growth rate (CAGR) of 16.2%. The growth in the forecast period can be attributed to growing demand for workflow optimization in neurosurgery, increasing preference for high performance battery operated surgical devices, rising investments in next generation neurosurgical equipment, expanding healthcare infrastructure in emerging economies, increasing focus on improving surgical outcomes and patient safety. Major trends in the forecast period include increasing adoption of cordless neurosurgical drilling systems, growing preference for lightweight ergonomic surgical handpieces, rising demand for high torque battery powered craniotomes, expanding use of rechargeable power systems in neurosurgical procedures, increasing focus on improving surgical precision and operating room efficiency.

The growing number of neurosurgical procedures is expected to drive the growth of the battery-operated neurosurgical power systems market in the coming years. Neurosurgical procedures refer to surgical interventions conducted on the brain, spinal cord, peripheral nerves, and cerebrovascular system to diagnose, treat, or manage neurological diseases, injuries, and disorders. The increasing volume of neurosurgical procedures is driven by the rising prevalence of neurological conditions, including brain tumors, strokes, and spinal disorders, which is creating greater demand for surgical treatments. Battery-operated neurosurgical power systems assist these procedures by providing cordless operation, improved precision, and dependable performance during complex cranial and spinal surgeries. For instance, in February 2026, according to the American Academy of Orthopaedic Surgeons (AAOS), a US-based orthopedic organization, the American Spine Registry included records of 466,078 cervical and lumbar spine procedures in 2024, representing a 36% increase compared with the previous annual report. Therefore, the increasing number of neurosurgical procedures is driving the growth of the battery-operated neurosurgical power systems market.

Key companies operating in the battery-operated neurosurgical power systems market are focusing on developing advanced solutions, such as cordless technologies with enhanced safety features and greater procedural versatility, to support a wider range of cranial and spinal surgeries. Cordless technologies help improve surgeon mobility, reduce cable-related interference in the operating room, enhance procedural efficiency, and support precise surgical performance. For example, in November 2025, Hubly Surgical, a US-based medical device company specializing in battery-powered neurosurgical technologies, received expanded FDA 510(k) clearance for its Hubly Auto-Stop Drill. The clearance extended the device's indications to include spinal decompression procedures, including laminectomy and laminotomy, strengthening the company's portfolio of battery-operated neurosurgical power systems. The expanded FDA 510(k) clearance broadens the clinical applications of the Hubly Auto-Stop Drill, allowing its use across a wider range of neurosurgical and spinal procedures. The device features an automatic stopping mechanism that is designed to enhance procedural precision by helping reduce the risk of unintended tissue penetration during bone drilling. With the expanded indication, Hubly Surgical aims to improve surgical workflow efficiency while meeting the increasing demand for portable, battery-powered neurosurgical instruments in operating rooms.

In March 2026, Nakanishi Inc., a Japan-based manufacturing company, acquired Acra-Cut Inc. for an undisclosed amount. Through this acquisition, Nakanishi intends to grow its surgical business operations, strengthen its neurosurgical power equipment portfolio, and improve its capabilities in cranial perforation systems and surgical drilling technologies. Acra-Cut is a US-based medical device manufacturer that develops neurosurgical power instruments, including battery-powered and other powered solutions used in cranial and spinal surgical procedures.

Major companies operating in the battery-operated neurosurgical power systems market report are Stryker Corporation, Medtronic plc, Integra LifeSciences Holdings Corporation, B. Braun Melsungen AG, KLS Martin Group, Bien-Air Surgery SA, Chongqing Xishan Science & Technology Co. Ltd., De Soutter Medical, Shanghai Bojin Electric Instrument & Device Co. Ltd., Nouvag AG, Micromar Indústria S.A., Hubly Surgical, NSK Ltd., RWD Life Science Co. Ltd., Aygün Surgical Instruments Co., Wuhu Ruijin Medical Instrument & Device Co. Ltd., Phasor Health.

North America was the dominant region in the battery-operated neurosurgical power systems market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the battery-operated neurosurgical power systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the battery-operated neurosurgical power systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.